Hi Folks: **Off Topic**
Those interested in clinical trials may find the following of interest: http://www.nytimes.com/2010/09/19/health/research/19trial.html It concerns the ethicality of randomizing those with life-threatening disease to relatively ineffective SOC when new "biologically targeted" therapies "appear" to be more effective. While the context may be new, the debate, itself, is not: Tukey wrote (or maybe it was talked -- I can't remember for sure) about this about 30 years ago. I'm sure many other also have done so. Cheers, Bert -- Bert Gunter Genentech Nonclinical Biostatistics ______________________________________________ R-help@r-project.org mailing list https://stat.ethz.ch/mailman/listinfo/r-help PLEASE do read the posting guide http://www.R-project.org/posting-guide.html and provide commented, minimal, self-contained, reproducible code.
